SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-019256
Filing Date
2019-05-15
Accepted
2019-05-15 07:01:33
Documents
66
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vcnx-10q_20190331.htm 10-Q 1383908
2 EX-31.1 vcnx-ex311_150.htm EX-31.1 19176
3 EX-31.2 vcnx-ex312_151.htm EX-31.2 19159
4 EX-32.1 vcnx-ex321_149.htm EX-32.1 11251
  Complete submission text file 0001564590-19-019256.txt   4951869

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vcnx-20190331.xml EX-101.INS 975522
6 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20190331.xsd EX-101.SCH 46201
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vcnx-20190331_cal.xml EX-101.CAL 35416
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcnx-20190331_def.xml EX-101.DEF 132349
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20190331_lab.xml EX-101.LAB 328387
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20190331_pre.xml EX-101.PRE 255584
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 19825030
SIC: 2834 Pharmaceutical Preparations